499 related articles for article (PubMed ID: 9030359)
1. HIV-1 Tat protein can transactivate a heterologous TATAA element independent of viral promoter sequences and the trans-activation response element.
Roebuck KA; Rabbi MF; Kagnoff MF
AIDS; 1997 Feb; 11(2):139-46. PubMed ID: 9030359
[TBL] [Abstract][Full Text] [Related]
2. Activating protein-1 cooperates with phorbol ester activation signals to increase HIV-1 expression.
Roebuck KA; Gu DS; Kagnoff MF
AIDS; 1996 Jul; 10(8):819-26. PubMed ID: 8828738
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
[TBL] [Abstract][Full Text] [Related]
4. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
[TBL] [Abstract][Full Text] [Related]
5. TAR and Sp1-independent transactivation of HIV long terminal repeat by the Tat protein in the presence of human cytomegalovirus IE1/IE2.
Dal Monte P; Landini MP; Sinclair J; Virelizier JL; Michelson S
AIDS; 1997 Mar; 11(3):297-303. PubMed ID: 9147420
[TBL] [Abstract][Full Text] [Related]
6. Transactivation of heterologous promoters by HIV-1 tat.
Han P; Brown R; Barsoum J
Nucleic Acids Res; 1991 Dec; 19(25):7225-9. PubMed ID: 1662814
[TBL] [Abstract][Full Text] [Related]
7. Effects of the tat and nef gene products of human immunodeficiency virus type 1 (HIV-1) on transcription controlled by the HIV-1 long terminal repeat and on cell growth in macrophages.
Murphy KM; Sweet MJ; Ross IL; Hume DA
J Virol; 1993 Dec; 67(12):6956-64. PubMed ID: 8230418
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Tat-mediated transactivation of HIV-1 LTR transcription by polyamide nucleic acid targeted to TAR hairpin element.
Mayhood T; Kaushik N; Pandey PK; Kashanchi F; Deng L; Pandey VN
Biochemistry; 2000 Sep; 39(38):11532-9. PubMed ID: 10995220
[TBL] [Abstract][Full Text] [Related]
9. The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence.
Tiley LS; Madore SJ; Malim MH; Cullen BR
Genes Dev; 1992 Nov; 6(11):2077-87. PubMed ID: 1427073
[TBL] [Abstract][Full Text] [Related]
10. Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription.
Bieniasz PD; Grdina TA; Bogerd HP; Cullen BR
Proc Natl Acad Sci U S A; 1999 Jul; 96(14):7791-6. PubMed ID: 10393900
[TBL] [Abstract][Full Text] [Related]
11. The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein.
Scala G; Ruocco MR; Ambrosino C; Mallardo M; Giordano V; Baldassarre F; Dragonetti E; Quinto I; Venuta S
J Exp Med; 1994 Mar; 179(3):961-71. PubMed ID: 8113688
[TBL] [Abstract][Full Text] [Related]
12. tat regulates binding of the human immunodeficiency virus trans-activating region RNA loop-binding protein TRP-185.
Wu F; Garcia J; Sigman D; Gaynor R
Genes Dev; 1991 Nov; 5(11):2128-40. PubMed ID: 1936997
[TBL] [Abstract][Full Text] [Related]
13. Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein.
Kamine J; Subramanian T; Chinnadurai G
Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8510-4. PubMed ID: 1924310
[TBL] [Abstract][Full Text] [Related]
14. Functional similarities between HIV-1 Tat and DNA sequence-specific transcriptional activators.
Madore SJ; Cullen BR
Virology; 1995 Feb; 206(2):1150-4. PubMed ID: 7856090
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of relative promoter strengths of the HIV-1-LTR and a chimeric RSV-LTR in T lymphocytic cells and peripheral blood mononuclear cells: promoters for anti-HIV-1 gene therapies.
Mukhtar M; Duan L; Bagasra O; Pomerantz RJ
Gene Ther; 1996 Aug; 3(8):725-30. PubMed ID: 8854098
[TBL] [Abstract][Full Text] [Related]
16. Synergism between Tat and VP16 in trans-activation of HIV-1 LTR.
Ghosh S; Selby MJ; Peterlin BM
J Mol Biol; 1993 Dec; 234(3):610-9. PubMed ID: 8254663
[TBL] [Abstract][Full Text] [Related]
17. Lack of responsiveness of a nuclear factor-kappaB-regulated promoter to transactivation by human immunodeficiency virus 1 Tat in HeLa cells.
Kelly GD; Morris CB; Offermann MK
Virology; 1999 Oct; 263(1):128-38. PubMed ID: 10544088
[TBL] [Abstract][Full Text] [Related]
18. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.
Beauparlant P; Kwon H; Clarke M; Lin R; Sonenberg N; Wainberg M; Hiscott J
J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193
[TBL] [Abstract][Full Text] [Related]
19. Examination of TAR-independent Trans activation by human immunodeficiency virus type 1 Tat in human glial cells.
Kim YS; Panganiban AT
J Neurosci Res; 1996 Mar; 43(6):652-66. PubMed ID: 8984195
[TBL] [Abstract][Full Text] [Related]
20. A sensitive promoter assay based on the transcriptional activator Tat of the HIV-1 virus.
Koken SE; van Wamel J; Berkhout B
Gene; 1994 Jul; 144(2):243-7. PubMed ID: 8039709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]